Litton Mark James

CIK 00016048343 companiesBOTHELL, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001604834

Recent Transactions

50 trades

Sale
LeonaBio, Inc.$ATHA
Common Stock
2026-01-02$6.88/sh−2,586→ 40,828 total
Exercise/Conversion
LeonaBio, Inc.$ATHA
Restricted Stock Units
2025-12-31−10,834→ 0 total
Exercise/Conversion
LeonaBio, Inc.$ATHA
Common Stock
2025-12-31+10,834→ 43,414 total
Sale
LeonaBio, Inc.$ATHA
Common Stock
2025-07-01$0.29/sh−25,123→ 325,802 total
Exercise/Conversion
LeonaBio, Inc.$ATHA
Common Stock
2025-06-30+108,334→ 350,925 total
Exercise/Conversion
LeonaBio, Inc.$ATHA
Restricted Stock Units
2025-06-30−108,334→ 108,333 total
Award
LeonaBio, Inc.$ATHA
Restricted Stock Units
2025-03-03+222,543→ 222,543 total
Award
LeonaBio, Inc.$ATHA
Stock Option (Right to Buy)
2025-03-03+333,815→ 333,815 total
Sale
LeonaBio, Inc.$ATHA
Common Stock
2025-01-02$0.56/sh−25,107→ 242,591 total
Exercise/Conversion
LeonaBio, Inc.$ATHA
Common Stock
2024-12-31+108,333→ 267,698 total
Exercise/Conversion
LeonaBio, Inc.$ATHA
Restricted Stock Units
2024-12-31−108,333→ 216,667 total
Award
LeonaBio, Inc.$ATHA
Restricted Stock Units
2024-10-03+325,000→ 325,000 total
Award
LeonaBio, Inc.$ATHA
Stock Option (Right to Buy)
2024-10-03+325,000→ 325,000 total
Award
LeonaBio, Inc.$ATHA
Stock Option (Right to Buy)
2024-10-03+325,000→ 325,000 total
Sale
LeonaBio, Inc.$ATHA
Common Stock
2024-09-05$0.57/sh−5,032→ 159,365 total
Award
LeonaBio, Inc.$ATHA
Common Stock
2024-09-03+20,000→ 164,397 total
Award
LeonaBio, Inc.$ATHA
Stock Option (Right to Buy)
2024-02-15+650,000→ 650,000 total
Sale
LeonaBio, Inc.$ATHA
Common Stock
2024-01-05$2.91/sh−4,820→ 144,397 total
Sale
LeonaBio, Inc.$ATHA
Common Stock
2024-01-05$2.91/sh−4,820→ 144,397 total
Award
LeonaBio, Inc.$ATHA
Common Stock
2024-01-04+20,000→ 149,217 total
Award
LeonaBio, Inc.$ATHA
Common Stock
2024-01-04+20,000→ 149,217 total
Award
LeonaBio, Inc.$ATHA
Stock Option (Right to Buy)
2023-01-27+425,000→ 425,000 total
Award
LeonaBio, Inc.$ATHA
Common Stock
2022-11-18$2.74/sh+662→ 129,217 total
Sale
LeonaBio, Inc.$ATHA
Common Stock
2022-06-23$2.69/sh−7,960→ 128,555 total
Award
LeonaBio, Inc.$ATHA
Common Stock
2022-06-22+20,000→ 136,515 total
Award
LeonaBio, Inc.$ATHA
Common Stock
2022-05-18$7.06/sh+757→ 116,515 total
Award
LeonaBio, Inc.$ATHA
Stock Option (Right to Buy)
2022-01-27+400,000→ 400,000 total
Award
LeonaBio, Inc.$ATHA
Common Stock
2021-11-18$12.51/sh+885→ 115,758 total
Exercise/Conversion
LeonaBio, Inc.$ATHA
Common Stock
2021-08-17$1.35/sh+50,440→ 114,873 total
Exercise/Conversion
LeonaBio, Inc.$ATHA
Stock Option (Right to Buy)
2021-08-17−50,440→ 100,880 total
Award
LeonaBio, Inc.$ATHA
Common Stock
2021-05-18$14.45/sh+867→ 64,433 total
Award
LeonaBio, Inc.$ATHA
Stock Option (Right to Buy)
2021-02-18+85,000→ 85,000 total
Conversion
LeonaBio, Inc.$ATHA
Common Stock
2020-09-22+6,563→ 6,563 total
Conversion
LeonaBio, Inc.$ATHA
Common Stock
2020-09-22+13,126→ 63,566 total
Conversion
LeonaBio, Inc.$ATHA
Series B-1 Preferred Stock
2020-09-22−6,563→ 0 total
Conversion
LeonaBio, Inc.$ATHA
Series B-1 Preferred Stock
2020-09-22−6,563→ 0 total
Conversion
LeonaBio, Inc.$ATHA
Series B Preferred Stock
2020-09-22−13,126→ 0 total
Conversion
LeonaBio, Inc.$ATHA
Common Stock
2020-09-22+6,563→ 6,563 total
Conversion
LeonaBio, Inc.$ATHA
Common Stock
2020-09-22+6,563→ 6,563 total
Conversion
LeonaBio, Inc.$ATHA
Series B-1 Preferred Stock
2020-09-22−6,563→ 0 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (right to buy)
2019-02-06+75,000→ 75,000 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (right to buy)
2019-02-06+25,000→ 25,000 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (right to buy)
2018-08-06+150,000→ 150,000 total
Exercise/Conversion
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2018-06-01−22,727→ 0 total
Sale
ALDER BIOPHARMACEUTICALS INC
Common Stock
2018-06-01$18.24/sh−4,474→ 102,189 total
Exercise/Conversion
ALDER BIOPHARMACEUTICALS INC
Common Stock
2018-06-01$0.99/sh+22,727→ 124,916 total
Sale
ALDER BIOPHARMACEUTICALS INC
Common Stock
2018-06-01$17.74/sh−18,253→ 106,663 total
Award
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2018-02-16+75,000→ 75,000 total
Exercise/Conversion
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2017-11-13−16,519→ 0 total
Sale
ALDER BIOPHARMACEUTICALS INC
Common Stock
2017-11-13$10.80/sh−16,519→ 99,932 total

Companies

Recent Filings

Address

C/O ATHIRA PHARMA, INC. 18706 NORTH CREEK PARKWAY, SUITE 104

BOTHELL, WA, 98011

View on SEC.gov